UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Decreased by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 5.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,219 shares of the healthcare conglomerate’s stock after selling 326 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in UnitedHealth Group were worth $2,733,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Montz Harcus Wealth Management LLC purchased a new stake in shares of UnitedHealth Group in the first quarter valued at $317,000. DB Fitzpatrick & Co Inc raised its holdings in UnitedHealth Group by 34.3% during the first quarter. DB Fitzpatrick & Co Inc now owns 2,227 shares of the healthcare conglomerate’s stock valued at $1,166,000 after buying an additional 569 shares in the last quarter. MGO Private Wealth LLC bought a new position in UnitedHealth Group during the first quarter valued at about $209,000. Centennial Wealth Advisory LLC increased its stake in shares of UnitedHealth Group by 9.7% in the first quarter. Centennial Wealth Advisory LLC now owns 906 shares of the healthcare conglomerate’s stock worth $475,000 after purchasing an additional 80 shares during the period. Finally, Davidson Capital Management Inc. increased its stake in shares of UnitedHealth Group by 3.4% in the first quarter. Davidson Capital Management Inc. now owns 6,077 shares of the healthcare conglomerate’s stock worth $3,183,000 after purchasing an additional 201 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director John H. Noseworthy bought 300 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on UNH shares. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Mizuho decreased their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Barclays dropped their price objective on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research report on Monday, June 2nd. Finally, Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $426.52.

Check Out Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Price Performance

UNH stock opened at $306.90 on Thursday. The stock has a 50-day moving average price of $370.86 and a two-hundred day moving average price of $467.96. The stock has a market cap of $278.40 billion, a PE ratio of 12.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business earned $6.91 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a $2.21 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.88%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.